Antibodies against HER2 truncated variant CTF-611

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8741586
APP PUB NO 20110135653A1
SERIAL NO

12961004

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method of diagnosis and therapy of cancers expressing the HER2 receptor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL D'HEBRON AN ENTERPRISE OPERATING UNDER THE LAWS OF SPAINPASSEIG VALL D'HEBRON 119-129 EDIFICI MATERN-INFANTIL PLANTA 14 BARCELONA 08035
FUNDACIO PRIVADA INSTITUCIO CATALANA DE RECERCA I ESTUDIS AVANCATS AN ENTERPRISE OPERATING UNDER THE LAWS OF SPAINPASSEIG LLUIS COMPANYS 23 BARCELONA 08010

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Angellini, Pier-Davide Barcelona, ES 2 24
Arribas, Lopez Joaquin Cerdanyola del Valles, ES 3 16
Baselga, Torres Jose Barcelona, ES 2 18
Parra, Palau Josep Lluis Barcelona, ES 1 6
Pedersen, Kim Barcelona, ES 5 61

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 3, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00